James Callaway's most recent trade in Xenetic Biosciences Inc was a trade of 2,500 Stock Options done . Disclosure was reported to the exchange on Dec. 6, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Xenetic Biosciences Inc | James Callaway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 2,500 | 2,500 | - | - | Stock Options | |
Xenetic Biosciences Inc | James Callaway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 25,000 | 25,000 | - | - | Stock Options |